OncoMed Pharmaceuticals Inc Deferred Revenue
OncoMed Pharmaceuticals Inc had Deferred Revenue of $27.92 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-05-08
- 2018-03-31: Deferred Revenue, Current $27.92M.
- 2017-12-31: Deferred Revenue, Current $82.19M.
- 2017-09-30: Deferred Revenue, Current $20.05M.
- 2017-06-30: Deferred Revenue, Current $20.05M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-03-31 | $27.92M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $82.19M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $20.05M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $20.05M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $20.19M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $20.51M 10-K · filed 2018-03-09 |
| 2016-09-30 | $20.80M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $21.06M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $21.39M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $21.54M 10-K · filed 2017-03-09 |
| 2015-09-30 | $15.10M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $16.52M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $17.64M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $18.75M 10-K · filed 2016-03-10 |
| 2014-09-30 | $21.19M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $34.63M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $35.06M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $35.06M 10-K · filed 2015-03-12 |
| 2013-09-30 | $22.73M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $22.73M 10-Q · filed 2013-09-03 |
| 2012-12-31 | $14.73M 10-K · filed 2014-03-18 |